Conference Coverage

The case for bariatric surgery to manage CV risk in diabetes

Publish date: June 9, 2018

 

EXPERT ANALYSIS FROM AACE 2018


“For treatment of type 2 diabetes and cardiovascular co-morbidities, long-term goals often are met following bariatric surgery versus behavior change,” said Dr. Hurley.

Dr. Hurley reported that he had no financial disclosures.

SOURCE: Hurley, D. AACE 2018, Session SGS-4.

Pages

Recommended Reading

Sleeve gastrectomy studied as an option for obese HIV-infected patients
MDedge Surgery
Morbid, super obesity raises laparoscopic VHR risk
MDedge Surgery
Pre–bariatric surgery weight loss improves outcomes
MDedge Surgery
No clear winner in Pfannenstiel vs. vertical incision for high BMI cesareans
MDedge Surgery
VIDEO: It is an exciting time in obesity treatment
MDedge Surgery
VIDEO: Intestinal remodeling contributes to HbA1c drop after Roux-en-Y gastric bypass
MDedge Surgery
Life and health are not even across the U.S.
MDedge Surgery
Figure-of-eight overstitch keeps endoscopic stents in place
MDedge Surgery
Bismuth subgallate cuts stool smell after duodenal switch
MDedge Surgery
FDA alerts clinicians to gastric balloon deaths
MDedge Surgery